Dymista fig 3

Figure 3. More seasonal allergic rhinitis patients treated with Dymista® first achieve substantial symptom control ( ie ≥50% reflective total nasal symptom score reduction from baseline) and did so up to six days faster than patients treated with FP or AZE. Reprinted with permission from Int Arch Allergy Immunol (S Karger AG, Basel)11